The implantable photovoltaic energy harvesting system implanted in the optimal location.
I. INTRODUCTION 1 iomedical implantable and wearable devices play a significant role in modern therapy and diagnosis [1] . Due to their clinical demand, a variety of subcutaneous devices such as defibrillators, pacemakers, cochlear implants, drug pumps, neurological stimulators and biomedical sensors are now being developed [2] [3] [4] [5] [6] [7] . Power harvesting or generation is still a big challenge in these devices. Due to the hazardous nature of batteries as well as their size, lifespan and the need for surgical replacement, alternative energy generation techniques are now in high demand [8] . Emerging power harvesters include Photovoltaic cells (PV), Piezoelectric Generators (PEG), Thermoelectric Cells (TEG), Biofuel Cells (BC), and Triboelectric nanogenerators (TENG). They can harvest energy from human fluids, the human body or the external environment [9] [10] [11] [12] [13] [14] . Another alternative method relies on Wireless Power Transfer (WPT), which enables power transfer between an external power source and an implantable device [15, 16] . The literature has demonstrated the feasibility of implanting these devices in small mammals [8, [17] [18] [19] , lobsters [20] , insects [21, 22] and snails [23] , with some research based on in-vitro testing [24] [25] [26] . Compared with other power harvesting techniques, WPT enables the device to be implanted in the human This paper is extended from the one presented in the 2018 IEEE Sensors Conference, held in New Delhi, India, 28th -31st October 2018. This work was supported by the Royal Society under grant RSG\R1\180269", EP/R511705/1 from the UK EPSRC. body [27] and is approved by the Food and Drug Administration (FDA) [8, 15] . PEG, TEG and TENG are designed to harvest energy produced by body fluids or temperature gradients. All of these require specific locations with high motion or temperature changes. BC is highly biocompatible with living organisms and has been tested with plants, insects and mammals [20-23, 28, 29] . Despite its low output voltage and enzymatic degradation, the abundance of glucose in living organisms makes it a feasible power harvesting technology for implantable devices. In WPT, the near-field inductive coupling method is mostly applied in implantable applications [15] . Large coil size, short power range and tissue loss are still unaddressed challenges [15, 30] . Ultrasonic power harvesting is one way to overcome these drawbacks, but the amount of power is lower than 1 mW [31] .
Compared with other technologies, PV cells can produce energy in the tens to hundreds of microwatts range within a relatively small area (mm 2 scale) [26, [32] [33] [34] [35] . Previous studies have shown that commercial PV cells are capable of powering an implantable pacemaker [26] . In L. Lu et al. 2018 [26] , monocrystalline cell arrays were designed and tested under a 4 mm skin layer (2 mm pork skin + 2 mm chicken muscle). Ultrathin and flexible photovoltaic cells were made using biocompatible encapsulation [26] .
Moreover, Hung et al. [35] demonstrated that the antireflective Silicon Nanowire (SINW) surface produced by low-temperature surface passivation can improve the output characteristics of CMOS PV cells (Maximum efficiency is 21.84% (under 5 mW/mm 2 condition) and 18.4% (under 0.5 mW/mm 2 ) without treatment.
Furthermore, the performance of these low-cost thin film PV cells can be significantly improved using various light trapping techniques [35] . Nevertheless, the temperature change from 15 o C to 45 o C can result in 10% output voltage reduction [35] . Similarly, Moon et al. show that an N + P -P + back-side illuminated crystalline silicon cell can harvest lowflux NIR light in subcutaneous conditions. An efficiency of 17.12% was achieved using a Si3N4 passivation layer on the illuminated surface [36] .
Tissue loss is still a challenge which limits the harvested energy of the PV cells. Maximum transmittance through human tissue occurs in the NIR spectral region. Silicon PV cells can therefore efficiently accumulate and convert energy according to their good response in NIR region [36] . However, the small incident power according to a small active area of implantable PV cell and a high recombination rate in NIR region can massively diminish the output characteristics [32] . Besides, each person's skin type (e.g. ethnic background, gender and age [37] [38] [39] ) can affect the PV cell's performance. For toxicity, there are some previous works showing feasibility to use silicon PV cells in implantable applications. In L. Lu 2018 et al. [26] , they implemented an ultrathin integrated solar cell array based on monocrystalline silicon microcells as a power supply, including the active layers, electrodes, interconnections, and encapsulation layers using fully biocompatible and biodegradable materials. In their study, they designed a 7day in-vivo test in a hairless rat. The cytotoxicity test provides good biocompatibility of the implantable PV cell. The obtained overall viability between 89% and 91% is consistent with an absence of any toxic effects. Throughout the duration of the experiment, the numbers of dead cells are significantly lower than that of the living cells, thereby providing evidence of good biocompatibility.
However, the literature provides little insight into the ideal position of implanting these PV cells. There is also no mentioning of the optimized device structure, which is important before any fabrication and implantation takes place. Consequently, we will present our optimized 2D PV cell structure using a simulation platform that relies on solving Maxwell's semiconductor equations. In addition, light propagation through the stratum corneum, epidermis, dermis and adipose will be modelled using the Jones matrix technique. Our energy harvesting PV device will be inserted in each of these different layers, as shown in Fig. 1 . We will therefore demonstrate the performance of the PV cell when it is placed in different skin locations and skin layers.
A. Semiconductor principles
Most PV cells are fabricated using semiconductor materials such as Si, GaAs and CdTe. According to the literature, organic materials are generating much interest due to their flexibility, low price and low fabrication costs. However, they still suffer from poor stability and a large active area is required due to their low conversion efficiency [40] . Most implantable PV cells are made of crystalline silicon due to their high efficiency and nontoxicity [40] . Consequently, we will therefore focus our study on semiconductor PV cells.
Carrier transport in the semiconductor layers can be simulated by invoking the Poisson and continuity equations (equations 1a and 1c). Moreover, we invoke Snell's law and Maxwell's equations to analyze light penetration using the Jones matrix method [41] . All these equations can be solved using the Finite Element Method (FEM) [42] . Thus,
where n and p are the electron and hole concentrations, ѱ is the electrostatic potential, q is the electron charge, ε is the permittivity of semiconductor, ND + and NAare the ionized donor and acceptor impurity concentrations, k is the Boltzmann constant, T is the ambient temperature, μn and μp are the electron and hole mobilities, Dn,p are the electron and hole diffusion coefficient (Dn,p=μn,pkT/q), and G and R present the generation rate and recombination rate of electron-hole pairs. The recombination rates (R) are composed of direct radiative (Rrad), Auger (RAu) and Shockley-Read-Hall (RSRH) recombination [42] :
where p1,n1 are the trap state hole/electron concentration, geh, geeh and gehh are the injection factors, B is the radiative 
where α(λ) is the absorption coefficient of semiconductor, b(λ) is the photon flux on the surface, Ps is the power flow according to various wavelengths and the depth into the device in x-and y-direction. The photon flux can be calculated from the light intensity of Air Mass 1.5 Global (AM1.5G).
B. Initial and boundary conditions
To begin, we apply the neutral charge condition to setup the doping profile and ohmic contact characteristics for estimating the initial electrostatic potential [41] . In our model, we enable periodic boundary conditions to analyze carrier diffusion and electrical potentials in the transverse directions. The Neumann boundary conditions are applied to separate the simulation domains. The fluxes across the boundaries were set to zero (ñ·E=0, ñ·Jn,p=0, ñ·Sn,p=0), where ñ is the outward-oriented vector.
C. Performance Characteristics
The electron current (Jn), hole current (Jp) and shortcircuit current (Jsc) can be determined using [41, 42] :
Considering the parasitic resistances, the output current density of the PV cell can be obtained using [41] : (5) where Rs and Rsh are the series and shunt parasitic resistances, and VT is the thermal voltage (VT=kq/T). Since our simulation model is in 2D, Rs can be neglected and Rsh can be calculated using the IV characteristic of the device. The External Quantum Efficiency (EQE) can be determined using [41, 42] : (6) where h is the Plank constant, c is the speed of light, Pin is the input power flux density (AM 1.5G light intensity).
A. Skin Model Description
The amount of electrical energy generated from the photovoltaic effect in subcutaneous conditions is highly related to the thickness and optical properties of skins [43] . In this section, we will demonstrate how we can constructed a model to simulate light propagation through the skin [26, 37, 43, 44] . Skin is composed of a number of layers that include the Stratum corneum, epidermis, dermis and hypodermis (adipose layer). According to K. Song et al. 2017 [43] , the thickness of each of these skin layers is inhomogeneous [43] and the thickness of the epidermis and dermis are between 32 µm and 1.8 mm, respectively. In fact, the thickness of each layer varies with different skin profiles. For example, the stratum corneum is ~10 µm, the epidermis is between 100 to 150 µm, the dermis is between 1 to 4 mm, and the hypodermis is between 1 mm to 6 mm [44] . Consequently, we apply a multi-layer skin structure by using a 10 µm stratum corneum, 100 µm epidermis, 1 mm dermis and 3 mm hypodermis, which is shown in Fig. 1 . The propagation of light through the skin can be modelled using a 2×2 characteristic matrix [45]:
where δi is the wave phase shift (δi=2πNidicosθi/λ) in the i th layer, Ni is the refractive index, di is the thickness of the i th layer, ηi is the pseudo index in i th layer (ηi=Nicosθi). ERa or BRa is the ratio between the (electric/magnetic) field of the transmitted light and the (electric/magnetic) field of the incident light. The reflectance (R), transmittance (T) and absorptance (A) of light can be determined using [45] :
II. MODEL VERIFICATION
Before device analysis and optimization, it is imperative to verify our model with experimental data. In this case, we setup a model of a single junction PV device using the parameters shown in Table I . The width and out-of-plane thickness of the cell are 1 mm and 1.22 mm respectively. We apply the analytical doping method to ensure a uniform doping concentration in each layer. The material properties are extracted from [46] [47] [48] [49] [50] [51] [52] [53] [54] . Comparisons between the reference cell [32] and simulations are shown in Figs. 2(a) and 2(b), demonstrating a good match between the results. The External Quantum Efficiency (EQE) of our model is high in both the visible and ultraviolet (UV) regions, due to the effective light reflections in both the front and rear planes. The JV curve shows a Voc of 0.44 V and a Jsc of 650 nA/cm 2 .
III. RESULTS AND DISCUSSION
In this section, we demonstrate the performance of our device in different skin layers. Initially, we optimized the device by changing the doping profile and geometry to improve the output performance using the parameters shown in Table I . The doping profile changes the band structure of the material, and the device performance is limited due to recombination losses, which reduces the open circuit voltage to less than the theoretical limit [32] . The thickness will affect the penetration of light, which will undoubtedly affect 1 cos ( / ) sin 1 sin cos Table I .
the amount of photo-generated current. In our design, we sweep the doping profile of the base layer, front layer and back layer, and then check the efficiency changes. Based on the inset of Fig. 2 (c) , optimal doping concentration for the base layer, front layer and back layer are 4.6×10 15 cm -3 , 1×10 19 cm -3 and 1×10 20 cm -3 , respectively. For the doping concentration in the front layer, we can obtain the same efficiency of 16.5% at both 1×10 16 cm -3 and 1×10 18 cm -3 . However, we preferred the light doping solution to avoid possible defects as a result of excessive doping during fabrication. The efficiencies according to the thickness of the base layer, front layer and back layer are shown in Fig. 2 (d) .
Based on this, we can obtain the optimal thickness of each layer: 50 μm (Base), 0.25 μm (Front) and 0.1 μm (Back). The baseline performance is shown in Fig. 3 under AM 1.5G condition (100 mW/cm 2 ). Our device can achieve 17.20 mW maximum power at 0.585 V with 17.20% efficiency. The open-circuit voltage is 0.675 V, and the short-circuit current density is 31.42 mA/cm 2 , which is shown in Fig. 3(h) as 'No skin'. The EQE of our device is shown in Fig. 3(g) , with a peak value of 75.80% at 750 nm.
The generation and recombination rates with a 550 nm light source are shown in Fig. 3(b) , which is obtained using equations (3) and (4) without skin. The generation rate improves with the depth increased, while there is a trade-off point between the generation and recombination rates at a depth of 0.23 µm. The electrons are separated and accelerated in the junction boundaries, which are shown as the peak value in Fig. 3(c) .
For illustration purposes, we demonstrate the refractive index of different skin layers in comparison to silicon PV cells, as shown in Fig. 3(d) . Obviously, skin has almost one third the refractive index of silicon. Similarly, the absorptance and transmittance of light through skin are shown in Fig. 3 (e) and Fig. 3(f) , respectively. Overall, since light propagations through more tissue, there will be a greater amount of attenuation. The epidermis predominantly absorbs the light in the UV and visible regions, with 60% of light absorbed at 350 nm. The dermis can absorb almost 40% of light from all spectra except in the NIR region, where an average of 20% is absorbed. The influence of the adipose layer is less when compared to the other layers, and a 3 mm and Transmittance (f) of the multilayer structure with scattering consideration. The structure is composed of 10 µm stratum corneum, 100 µm epidermis, 1 mm dermis and 3 mm adipose (or hypodermis). It clearly shows that the transmittance of skin is dramatically degraded with scattering considered. The reflectance is neglected due to its small value (0.1%). Besides, it shows that the adipose layer causes less influence in light penetration into the tissue. (g) and (h) show the electric performance of the devices: EQE according to spectra, where the peak wavelengths are 750 nm (No skin), 800 nm (A), 832 nm (B without scattering), 850 nm (B) and 850 nm (C). and JV curves of different implanting location according to a wavelength of 550 nm. (i) shows the JV curves when the device is illuminated in peak wavelength obtained from Fig. 3(g) , 100 mW/cm 2 @ 800 nm (A), 832 nm (B without scattering), 850 nm (B) and 850 nm (C).
adipose can only cause 7% attenuation of light at 550 nm, in comparison to 10% loss at 850 nm, respectively. The transmittance is inversely proportional to the skin absorptance due to the small skin reflectance (less than 3%). Fig. 3 (g) shows the EQE according to different implant layers. When the device is implanted in Test Point A, an EQE of 67.50% can be achieved at the peak wavelength of 800 nm. When implanted in Test Point B, an EQE of 55.60% (Scattered) and 43.30% (Non-scattered) can be achieved at the peak wavelength of 832 nm and 850 nm, respectively. When implanted in Test Point C, the EQE is 38.50% at the peak wavelength of 850 nm. Fig. 3(h) shows the JV characteristics under 1 Sun illumination conditions (i.e. 100 mW/cm 2 at 550 nm) when the device is implanted in a different layer of human tissue as well as without tissue. The short circuit current density, Jsc, decreases from 24.40 mA/cm 2 to 8.21 mA/cm 2 , and the open circuit voltage, Voc, decreases from 0.670 V to 0.620 V. Furthermore, the maximum power, Pmax, can be determined using the JV curves in Figs. 3(h) and 3(i). The power therefore decreases from 13.36 ± 1 mW to 4.16 ± 1 mW. The skin transmittance influences the light illumination at the device surface, and the generation rate will be degraded according to the Eq. 4. The Voc is related to the generation rate, which is qualitatively consistent with the decrease in Voc (7.46%) [26] . Fig. 3 (i) shows the JV characteristics at different test point when illuminated in the peak wavelength. Light attenuation through skin (Between A and C) causes 11 mA/cm 2 difference of Jsc, 0.02 V difference in Voc, and 6.43 mW difference in Pmax. The device will generate the highest amount of power in point B by illuminating it at the peak wavelength, which is 11.84 mW. Considering the power output, the dermis layer (between points A and B) is the best implant location, since it enables the PV cell to generate 15 mW for an 800 nm light source and 13 mW for a 550 nm source. However, depending upon the type of light source and the implantation depth, the amount of harvested power will vary. For example, if the device is implanted in the narrow region between points A and B, it will generate up to 8.57 mW for a white light source and 3.45 mW for NIR light. This region is typically 1mm in depth. However, if the device is implanted between points B and C, which is almost 3 mm, it will generate 0.63 mW for a white light source and 2.98 mW for NIR light. Consequently, we recommend implanting our PV cells between regions B and C since it is thicker, which makes it easier to implant in the human body and the amount of harvested power is constant within this region. To overcome the high amount of attenuation, we recommend using NIR light.
Another phenomenon that affects the performance of our PV cells is light scattering, which may be due to blood and water content in the skin layers. By implanting the device in point B, scattering causes a 47% drop in power at 550 nm and 9% at 850 nm. Similarly, implanting the device in location C results in 28% drop using NIR light and 52% using white light. Table II compares our work with previously published work [25, 32, 43, 55] . Our proposed implantation location (between B and C), illumination wavelength (NIR light) and optimised PV cell clearly harvests higher power (> 8.35 mW/cm 2 ) than the literature. Despite of the comparison between the different PV cells, our cell can also compare with the other energy harvesters. For output voltage, PV cells are less restricted by the size of the organ or the depth of the implants compared with the other energy harvesters, which is shown in Figs. 3(h) and 3(i). In the system level, Some energy harvesters such as PEG, TENG and WPT are considered as an AC sources, while the implantable PV cell is considered as a DC source, relaxing the additional loss due to the extra AC-DC power conversion stage [8] .
IV. CONCLUSION
We have demonstrated the performance of an implantable PV device using the FEM method. In our design, PV cells implanted in the adipose layer can harvest nearly 11.84 mW using an 850 nm light source. This power can drive implantable devices such as pacemakers and biomedical sensors. The epidermis layer absorbs most of the visible light, and the dermis layer absorbs most of the NIR light. We further concluded that the dermis layer is a good location for implantable PV cell to acquire a high-power output, and the adipose layer is an excellent location to obtain a stable power output. NIR light enables high skin transmittance and low scattering losses, which is beneficial for the PV cell, but may be hazardous for the human body due to possible heating effects. In future, we will investigate the effect of heat on the device performance, as well as the biocompatibility of the PV device with the human body. We will also investigate [25] p-n GaAs 134 μW/cm 2 LED Rat 4 mm 1.22 mW/cm 2 (c) [32] p-n Si One Sun Human inner arm 0.951 ± 0.335 mm 3.5 mW/cm 2 (d) [43] GaAs:GaInP One Sun Rat 675 µm 4.5 mW/cm 2 (e) [55] n-p-p Si 100 mW/cm 2 850nm IR light Human outer arm 4 mm 8.35 mW/cm 2 (f) This work a Power density can vary according to different experimental conditions. The following indicates the references. b Measured by using 3 mm pork skin in-vitro. c Measured under 4 mm Rat skin in-vitro, and an LED light source. d Measured by using fresh skin from human (Asian 95 years old) in 26 hours after death without embalming process. e Measured in vivo using hairless rat. f Simulated by using the measured in-vivo human skin properties from literature. The implant location is just under dermis. the power transfer between the power harvester and load for the in-vitro tests after completing system integration and device encapsulation.
